LITEVAX
LiteVax is a biotechnology company that creates vaccines against infectious and non-infectious diseases.
LITEVAX
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Oss, Noord-Brabant, The Netherlands
Country:
The Netherlands
Website Url:
http://www.litevax.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Euro COVID-19 WP Rocket
Similar Organizations
Genoskin
Genoskin is a biotechnology company located in Toulouse.
Hera Biotech
Hera Biotech is a biotechnology company that is mainly developed for women's health and reproductive medicines.
Q-linea
Q-linea is a privately held company that develops and sells applications and systems for detecting, for example, biological warfare agents.
Synvia
Synvia is a holding company that focuses on innovation in drug studies, drug development and performing toxicological test services.
Vaiomer
Vaiomer is a biotech company and contract research organization expert in tissue and blood microbiota.
Official Site Inspections
http://www.litevax.com
- Host name: 203.157.214.35.bc.googleusercontent.com
- IP address: 35.214.157.203
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "LiteVax"
Litevax
LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by …See details»
Company – Litevax
LiteVax B.V. is a privately held company with limited liability established in 2012 with laboratory and office at Pivot Park in Oss, The Netherlands. Their expertise and passion is research and …See details»
LiteVax - Crunchbase Company Profile & Funding
LiteVax is a biotechnology company that creates vaccines against infectious and non-infectious diseases. New. Resources. ... Experience the new …See details»
LiteVax - VentureRadar
LiteVax BV is a biopharmaceutical company focusing on the development and exploitation of novel adjuvant concepts. Our mission is to contribute to global health by delivering improved …See details»
LiteVax B.V. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for LiteVax B.V. of Ophemert, Gelderland. Get the latest business insights from Dun & Bradstreet.See details»
Technology - Litevax
These molecules are the outcome of extensive lead finding and optimization of efficacy/toxicity-ratio in large, non-rodent species. Our most advanced product known as ‘LiteVax Adjuvant’ is …See details»
LiteVax - Overview, News & Similar companies | ZoomInfo.com
LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy. New and more …See details»
LiteVax - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. LiteVax . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 13. About. LiteVax is actively using 13 …See details»
Litevax B V (Litevax B V) - National University of Singapore
TETRALITE is a novel, inactivated, adjuvanted influenza vaccine combining a low dose of a licensed vaccine with the novel, potent LiteVax Adjuvant. A licensed vaccine (Cohort 1) with a …See details»
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre …
LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine efficacy. New and more …See details»
☑️LiteVax B.V. — Consulting Organization from the Netherlands ...
LiteVax B.V. — Consulting Organization from the Netherlands, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Industry, Commerce & Services, Laboratory & …See details»
COVID Vaccine Collaboration | ImmunoPrecise Antibodies
Oss, Netherlands, June 22, 2020 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE:TQB2), and LiteVax BV (“LiteVax”) (the …See details»
Strategy - Litevax
LiteVax Adjuvant demonstrated unprecedented performance in preclinical models. In clinical trials with seasonal influenza vaccine supplemented with LiteVax Adjuvant, non-inferiority of low …See details»
Collaborative COVID-19 Vaccine Project Between ImmunoPrecise …
Jun 22, 2020 LiteVax and ImmunoPrecise may not be able to negotiate the terms for further development or commercialization of any product resulting from the collaboration. actual …See details»
Phase 1 trial with a novel, adjuvanted, low-dose influenza vaccine ...
LiteVax BV is a biopharmaceutical company focusing on the development of novel vaccine adjuvants. The versatile adjuvant technology exploited in TETRALITE is based on a synthetic …See details»
LiteVax BV - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 28, 2025 LiteVax BV is a funded company based in Oss (Netherlands), founded in 2012. It operates as a Dutch biopharma developing vaccine adjuvants to improve efficacy of vaccines …See details»
Projects - Litevax
The project largely builds on LiteVax’s proprietary technology. PCV-LITE; Development of a non-inferior fractional-dose pneumococcal conjugate vaccine (PCV) concept. In a recent preclinical …See details»
LiteVax started Phase 1 trial with a novel, adjuvanted, low-dose ...
LiteVax BV is a biopharmaceutical company focusing on the development of novel vaccine adjuvants. The versatile adjuvant technology exploited in TETRALITE is based on a synthetic …See details»
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre …
Sep 25, 2020 About LiteVax LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel immunoadjuvants to increase vaccine …See details»
News - Litevax
The phase 1b clinical study is a follow-up of the first-in-human trial, and will evaluate the safety, immunogenicity and immunological mechanisms of the novel LiteVax Adjuvant added to a full …See details»